Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 37.30M | $ 43.90M | $ 57.00M | $ 40.70M | $ 32.60M |
Total Assets | $ 3.53B | $ 3.66B | $ 3.05B | $ 2.63B | $ 2.48B |
Total Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Net Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Total Liabilities | $ 1.25B | $ 1.09B | $ 1.09B | $ 888.70M | $ 879.90M |
Stockholders Equity | $ 2.27B | $ 2.56B | $ 1.95B | $ 1.73B | $ 1.60B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |